Novo Nordisk

Novo taps e-therapeutics for diabetes target discovery drive
Novo taps e-therapeutics for diabetes target discovery drive
Fierce Biotech
Novo Nordisk
e-therapeutics
R&D
drug development
Flag link:
Novo keeps adding capacity, and jobs, to its North Carolina drug plant
Novo keeps adding capacity, and jobs, to its North Carolina drug plant
Fierce Pharma
Novo Nordisk
drug manufacturing
diabetes
North Carolina
Flag link:
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Novo Nordisk’s diabetes pill clears cardiac safety hurdle
Pharmaforum
Novo Nordisk
semaglutides
type 2 diabetes
clinical trials
cardiovascular outcomes
Flag link:
Novo Nordisk staff cull swells to 1,300
Novo Nordisk staff cull swells to 1,300
Pharmaforum
Novo Nordisk
layoffs
artificial intelligence
Flag link:
Weeks after launching Aeterna Zentaris castoff, Strongbridge turns around and sells rights to Novo Nordisk — at a premium
Weeks after launching Aeterna Zentaris castoff, Strongbridge turns around and sells rights to Novo Nordisk — at a premium
Endpoints
Strongbridge
Aeterna Zentaris
Macrilen
Novo Nordisk
adult growth hormone deficiency
Flag link:
Digital diabetes mavens Novo Nordisk and Sanofi top new patient experience ranking
Digital diabetes mavens Novo Nordisk and Sanofi top new patient experience ranking
Fierce Pharma
patients
patient experience data
Sanofi
Novo Nordisk
type 2 diabetes
Flag link:
Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Minnesota takes aim at Sanofi, Novo, Lilly for insulin prices
Biopharma Dive
Minnesota
insulin
diabetes
PBMs
Sanofi
Novo Nordisk
Eli Lilly
Flag link:
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
CP Wire
Anthem
Novo Nordisk
Ozempic
type 2 diabetes
Flag link:
Anthem, HealthCore and Novo Nordisk for Partnership to Study Benefits New Type 2 Diabetes Drug Vs Other Available Drugs
Anthem
Novo Nordisk
Ozempic
type 2 diabetes
Flag link:
Novo Nordisk picks AstraZeneca executive to head biopharma business
Novo Nordisk picks AstraZeneca executive to head biopharma business
Yahoo/Reuters
Novo Nordisk
AstraZeneca
Ludovic Helfgott
Flag link:
Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results
Eli Lilly ushers up-and-coming GIP/GLP-1 drug into PhIII as Novo Nordisk rival wows with impressive results
Endpoints
Eli Lilly
diabetes
Novo Nordisk
Ozempic
LY3298176
Trulicity
Flag link:
Novo to market ‘connected’ insulin pens next year
Novo to market ‘connected’ insulin pens next year
Pharmaforum
Novo Nordisk
insulin pen
devices
connected insulin pen
diabetes
Flag link:
Novo to create California stem cell therapy manufacturing site
Novo to create California stem cell therapy manufacturing site
Pharmaforum
Novo Nordisk
stem cells
drug manufacturing
California
Flag link:
On the heels of a global R&D reorganization, Novo Nordisk outlines 250 US job cuts
On the heels of a global R&D reorganization, Novo Nordisk outlines 250 US job cuts
Endpoints
Novo Nordisk
layoffs
reorganization
Flag link:
Novo Nordisk to Lay off 400 to Focus on Innovation
Novo Nordisk to Lay off 400 to Focus on Innovation
BioSpace
Novo Nordisk
R&D
layoffs
Denmark
China
Flag link:
Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production
Pfizer, Glaxo, Novo, Novartis plants unfazed by hurricane, resume production
Fierce Pharma
Pfizer
GSK
Novo Nordisk
Novartis
drug manufacturing
hurricanes
Flag link:
Novo Nordisk CEO reassures UK patients over Brexit insulin supplies
Novo Nordisk CEO reassures UK patients over Brexit insulin supplies
Pharmaforum
Novo Nordisk
insulin
UK
Brexit
Flag link:
Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in
Novartis, Novo, Glaxo and others hunker down as hurricane sweeps in
Fierce Pharma
Novartis
Novo Nordisk
Pfizer
GSK
hurricanes
Flag link:
Novo Nordisk adds to diabetes pipeline with Evotec deal
Novo Nordisk adds to diabetes pipeline with Evotec deal
Fierce Biotech
Novo Nordisk
Evotec
drug development
small molecule drugs
obesity
diabetes
Flag link:
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
Novo Nordisk’s Semaglutide Hits Mark in Type 2 Diabetes Trial
BioSpace
Novo Nordisk
clinical trials
semaglutide
type 2 diabetes
Flag link:

Pages